ASXC News and Press, Asensus Surgical Inc Com From 11/02/22

The following slide deck was published by Asensus Surgical, Inc. in conjunction with this event. For further details see: Asensus Surgical (ASXC) Investor Presentation - Slideshow

RESEARCH TRIANGLE PARK, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that i...

Presentation on Tuesday, October 25 at 8:30 am PT Research Triangle Park, North Carolina--(Newsfile Corp. - October 18, 2022) - Asensus Surgical, Inc. (NYSE American: ASXC), Asensus Surgical, a medical device company that is digitizing the interface between the surgeon and the patient to pion...

RESEARCH TRIANGLE PARK, N.C., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Clinic...

RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Saiseikai ...

The shares of medical device maker Asensus Surgical, Inc. ( NYSE: ASXC ) traded higher on Thursday after Cantor Fitzgerald launched its coverage with an Overweight rating citing its prospects in laparoscopy, a surgical procedure to access the pelvis and abdomen. ASXC, a co...

RESEARCH TRIANGLE PARK, N.C., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the install...

Asensus Surgical, Inc. (ASXC) Q2 2022 Earnings Conference Call August 8, 2022 16:30 ET Company Participants Mark Klausner - Investor Relations Anthony Fernando - President and Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conference Ca...

Asensus Surgical press release ( NYSE: ASXC ): Q2 Non-GAAP EPS of -$0.07. Revenue of $1M (-9.1% Y/Y). Shares +4.8% . Total operating expenses were $18.2 million, as compared to $14.8 million, in the three months ended June 30, 2021. For the full year 2022, ...

RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operati...